🇺🇸 FDA
Patent

US 6756055

Cationic lipid compositions targeting angiogenic endothelial cells

expired A61KA61K47/54A61K47/543

Quick answer

US patent 6756055 (Cationic lipid compositions targeting angiogenic endothelial cells) held by The Regents of the University of California expires Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 29 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K47/54, A61K47/543, A61K49/0032, A61K49/0041